This inventor holds 1 USPTO granted patent. Top assignees: The United States of America as Represented by the Department of Health, University of Colorado. Active years: 1986.
Company Filing History:
1 out of 1,217 
1 out of 1,443 
Years Active: 1986
Title: Steven D Averbuch: Innovator in Biochemical Rescue Agents
Introduction
Steven D Averbuch is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biochemistry, particularly in developing compounds that serve as rescue agents against tissue damage caused by certain chemotherapy drugs.
Latest Patents
Averbuch holds a patent for his invention titled "Oxomorpholinyl dimer and rescue of anthracycline and mitomycin C damage." This patent discloses a bi(3,5-dimethyl-5-hydroxymethyl-2-oxomorpholin-3-yl) compound and its efficacy as a rescue agent against anthracycline and mitomycin C induced tissue damage. The patent also describes a method for synthesizing this compound, showcasing Averbuch's innovative approach to addressing critical issues in cancer treatment.
Career Highlights
Throughout his career, Averbuch has worked with esteemed organizations, including the United States of America as Represented by the Department of Health and the University of Colorado. His work has been instrumental in advancing the understanding and application of biochemical agents in medical treatments.
Collaborations
Averbuch has collaborated with notable colleagues such as Nicholas R Bachur and Giorgio Gaudiano. These partnerships have contributed to the development and refinement of his innovative ideas and patents.
Conclusion
Steven D Averbuch is a distinguished inventor whose work in developing rescue agents for chemotherapy-induced damage has the potential to significantly impact cancer treatment. His contributions to biochemistry and collaboration with esteemed institutions highlight his commitment to advancing medical science.